GRCE
Grace Therapeutics, Inc. Common Stock
GRCE
GRCE
25 hedge funds and large institutions have $1.32M invested in Grace Therapeutics, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$452K |
| 2 |
VF
2
Virtu Financial
New York
|
$118K |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$99K |
| 4 |
4
Jane Street
New York
|
$6K |
| 5 |
5
Two Sigma Advisers
New York
|
$171K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ASN
26
Advisory Services Network
Atlanta,
Georgia
| – | – | -2,000 | Closed |
|
27
Barclays
London,
United Kingdom
| $0 | 34 | -679 | -95% |
|
|
AF
28
Advisornet Financial
Minnetonka,
Minnesota
| $0 | 300 | – | – |
|
|
CFGS
29
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|